JPMorgan Chase & Co. Forecasts Strong Price Appreciation for HCA Healthcare (NYSE:HCA) Stock

HCA Healthcare logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • JPMorgan raised its HCA Healthcare price target from $425 to $475 but maintained a neutral rating; the target implied 2.31% downside from the share price at the time of the report.
  • Analyst sentiment overall remained positive: MarketBeat reported a “Moderate Buy” consensus and an average price target of $482.30, based on 16 Buy, 7 Hold, and 1 Sell ratings.
  • HCA beat quarterly expectations, reporting EPS of $7.22 versus $6.65 estimated and revenue of $19.85 billion versus $19.33 billion; revenue grew 3.6% year over year.
  • MarketBeat previews the top five stocks to own by December 1st.

HCA Healthcare (NYSE:HCA - Get Free Report) had its price target boosted by analysts at JPMorgan Chase & Co. from $425.00 to $475.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price objective suggests a potential downside of 2.31% from the company's current price.

Several other analysts also recently commented on the stock. Oppenheimer reduced their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating for the company in a research report on Monday, July 27th. Weiss Ratings upgraded shares of HCA Healthcare from a "buy (b-)" rating to a "buy (b)" rating in a research report on Tuesday, November 10th. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $381.00 to $468.00 and gave the stock an "equal weight" rating in a research note on Monday, November 2nd. KeyCorp raised their price target on shares of HCA Healthcare from $435.00 to $490.00 and gave the stock an "overweight" rating in a report on Wednesday, October 28th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating on shares of HCA Healthcare in a research note on Friday, October 2nd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $482.30.

Check Out Our Latest Stock Report on HCA

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded down $14.95 during midday trading on Wednesday, reaching $486.24. The company's stock had a trading volume of 228,913 shares, compared to its average volume of 1,340,901. HCA Healthcare has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The firm has a 50 day moving average price of $456.91 and a two-hundred day moving average price of $446.11. The firm has a market capitalization of $101.57 billion, a price-to-earnings ratio of 16.11, a PEG ratio of 1.71 and a beta of 1.11.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The business had revenue of $19.85 billion during the quarter, compared to analysts' expectations of $19.33 billion. During the same quarter last year, the firm posted $6.96 earnings per share. The firm's revenue was up 3.6% on a year-over-year basis. As a group, research analysts anticipate that HCA Healthcare will post 30.14 earnings per share for the current year.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael Schlosser sold 1,200 shares of the business's stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $494.65, for a total transaction of $593,580.00. Following the completion of the sale, the executive vice president owned 1,443 shares in the company, valued at approximately $713,779.95. The trade was a 45.40% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Jon Foster sold 21,713 shares of the firm's stock in a transaction on Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the transaction, the chief operating officer directly owned 10,000 shares in the company, valued at $4,949,500. This trade represents a 68.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 36,413 shares of company stock worth $18,251,464. 1.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds have recently added to or reduced their stakes in the stock. Zacks Investment Management lifted its position in HCA Healthcare by 20.0% in the third quarter. Zacks Investment Management now owns 901 shares of the company's stock valued at $385,000 after purchasing an additional 150 shares during the last quarter. Integrated Wealth Concepts LLC grew its holdings in shares of HCA Healthcare by 34.0% in the third quarter. Integrated Wealth Concepts LLC now owns 2,995 shares of the company's stock worth $1,278,000 after purchasing an additional 760 shares during the last quarter. Applied Capital LLC purchased a new position in shares of HCA Healthcare in the third quarter worth $216,000. Groupama Asset Managment raised its holdings in HCA Healthcare by 1.6% during the 3rd quarter. Groupama Asset Managment now owns 30,362 shares of the company's stock valued at $12,957,000 after buying an additional 483 shares during the last quarter. Finally, Diversify Wealth Management LLC boosted its position in HCA Healthcare by 3.3% during the 3rd quarter. Diversify Wealth Management LLC now owns 806 shares of the company's stock valued at $378,000 after buying an additional 26 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

About HCA Healthcare

(Get Free Report)

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

Recommended Stories

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines